Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Current Pharmaceutical Biotechnology
|
January 28, 2012
Genetics of hypertrophic and dilated cardiomyopathy
Felix W Friedrich, Lucie Carrier
International Journal of Chronic Obstructive Pulmonary Disease
|
July 2, 2020
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice - Results of the Non-Interventional DETECT Study
Tanja Plate, Felix W Friedrich, Jutta Beier
Frontiers in Physiology
|
August 22, 2017
Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
Sabrina Stücker, Nico Kresin, Lucie Carrier, et al.
Frontiers in Physiology
|
December 21, 2016
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca<sup>2+</sup> Transient Decay and Desensitizes Myofilaments in Healthy and <i>Mybpc3</i>-Targeted Knock-in Cardiomyopathic Mice
Felix W Friedrich, Frederik Flenner, Mahtab Nasib, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 1, 2021
COPD Exacerbation History and Impact on Future Exacerbations - 8-Year Retrospective Observational Database Cohort Study from Germany
Claus F Vogelmeier, Joanna Diesing, Nils Kossack, et al.
European Journal of Pharmacology
|
May 13, 2021
Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse model
Silke Düsener, Frederik Flenner, Christoph Maack, et al.
Scientific Reports
|
April 7, 2019
Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF<sub>2α</sub> in patients with myocardial infarction in the randomized RIMINI-Trial
Tjark F Schwemer, Navina Deutscher, Nadine Diermann, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 26, 2018
Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial
Tjark F Schwemer, Lukas Radziwolek, Navina Deutscher, et al.
The Journal of Physiology
|
January 17, 2017
Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice
Frederik Flenner, Birgit Geertz, Silke Reischmann-Düsener, et al.
Respiratory Medicine
|
December 27, 2023
Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
Claus F Vogelmeier, Felix W Friedrich, Patrick Timpel, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Current Pharmaceutical Biotechnology
|
January 28, 2012
Genetics of hypertrophic and dilated cardiomyopathy
Felix W Friedrich, Lucie Carrier
International Journal of Chronic Obstructive Pulmonary Disease
|
July 2, 2020
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice - Results of the Non-Interventional DETECT Study
Tanja Plate, Felix W Friedrich, Jutta Beier
Frontiers in Physiology
|
August 22, 2017
Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
Sabrina Stücker, Nico Kresin, Lucie Carrier, et al.
Frontiers in Physiology
|
December 21, 2016
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca<sup>2+</sup> Transient Decay and Desensitizes Myofilaments in Healthy and <i>Mybpc3</i>-Targeted Knock-in Cardiomyopathic Mice
Felix W Friedrich, Frederik Flenner, Mahtab Nasib, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
September 1, 2021
COPD Exacerbation History and Impact on Future Exacerbations - 8-Year Retrospective Observational Database Cohort Study from Germany
Claus F Vogelmeier, Joanna Diesing, Nils Kossack, et al.
European Journal of Pharmacology
|
May 13, 2021
Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse model
Silke Düsener, Frederik Flenner, Christoph Maack, et al.
Scientific Reports
|
April 7, 2019
Effect of ranolazine on plasma arginine derivatives and urinary isoprostane 8-iso-PGF<sub>2α</sub> in patients with myocardial infarction in the randomized RIMINI-Trial
Tjark F Schwemer, Navina Deutscher, Nadine Diermann, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 26, 2018
Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial
Tjark F Schwemer, Lukas Radziwolek, Navina Deutscher, et al.
The Journal of Physiology
|
January 17, 2017
Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice
Frederik Flenner, Birgit Geertz, Silke Reischmann-Düsener, et al.
Respiratory Medicine
|
December 27, 2023
Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study
Claus F Vogelmeier, Felix W Friedrich, Patrick Timpel, et al.
Page
of 4